Instil Bio Inc (TIL)
26.45
+1.69
(+6.83%)
USD |
NASDAQ |
Nov 22, 13:27
Instil Bio Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2020 | 0.052M |
June 30, 2020 | 0.042M |
Date | Value |
---|---|
March 31, 2020 | 0.044M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.042M
Minimum
Jun 2020
0.052M
Maximum
Sep 2020
0.046M
Average
0.044M
Median
Mar 2020
Revenue (Quarterly) Benchmarks
Merck & Co Inc | 16.66B |
Elite Pharmaceuticals Inc | 18.88M |
BioCardia Inc | -- |
Zevra Therapeutics Inc | 3.695M |
NovaBay Pharmaceuticals Inc | 2.441M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -23.02M |
Total Expenses (Quarterly) | 11.27M |
EPS Diluted (Quarterly) | -3.54 |
Enterprise Value | 123.40M |
Earnings Yield | -43.71% |